logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
D

Daniel J. George

Duke Cancer Institute
H指数:50
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical and genomic determinants of extraordinary response and resistance to androgen receptor pathway inhibitors in men with metastatic androgen pathway modulator sensitive (APMS) prostate cancer

转移性雄激素通路调节剂敏感(APMS)前列腺癌患者对雄激素受体通路抑制剂表现出超常反应和耐药性的临床及基因组决定因素

Prostate Cancer and Prostatic Diseases
IF5.8
2026-08-050
OAAI
Jane McKenzie; Lauren Howard; Joseph J. Park; Bilal Ashraf; Tara Seibert; Kallie White; Sundhar Ramalingam; Jeffrey W. Shevach; Michael R. Harrison; Christopher Hoimes; Matthew Labriola; Jordan Infield; Dillon Cockrell; Hannah D. McManus; Daniel J. George; Andrew J. Armstrong
Efficacy and safety of darolutamide plus androgen-deprivation therapy in Black patients with metastatic hormone-sensitive prostate cancer from the phase 3 ARANOTE trial

达罗鲁胺联合雄激素剥夺疗法在黑种人转移性激素敏感性前列腺癌患者中的有效性与安全性：来自III期ARANOTE试验的数据

Prostate Cancer and Prostatic Diseases
IF5.8
2026-06-200
OA
Quoc-Dien Trinh; Daniel J. George; Neal Shore; Egils Vjaters; David Olmos; Andrea Juliana P. de Santana Gomes; Augusto Cesar de Andrade Mota; Natasha Littleton; Shankar Srinivasan; Frank Verholen; Kunhi Parambath Haresh; Fred Saad
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression

EMETPRO：一项多中心、国际性回顾性分析，评估早期进展的转移性激素敏感性前列腺癌患者

Prostate Cancer and Prostatic Diseases
IF5.8
2026-05-290
PRE
Fabio Turco; Silke Gillessen; Giuseppe Salfi; Iris S. H. Kloots; Peter H. J. Slootbeek; Niven Mehra; Matthew Labriola; Daniel J. George; Amanda Broderick; Anna Patrikidou; Hortense Patry; Consuelo Buttigliero; Veronica Crespi; Hirotsugu Uemura; Kazutoshi Fujita; Takanobu Utsumi; Hiroyoshi Suzuki; Daniele Raggi; Umberto Basso; Rafael Morales-Barrera; David Marmolejo Castaneda; Cora N. Sternberg; Daniela Guevara; Orazio Caffo; Giuseppe Procopio; Andrea Zivi; Sara Merler; Mariella Sorarù; Daniel E. Spratt; Pedro C. Barata; Carlo Messina; Yüksel ürün; Hatice Bolek; Ignacio Duràn; Juan Diego Cacho Lavin; Nieves Martínez Chanzá; Lisa G. Horvath; Rhiannon Mellor; Levent Türkeri; Merve Bengisu Soykök; Sabrina Rossetti; Richard Cathomas; Giuseppe Luigi Banna; Vincenza Conteduca; Margaret Ottaviano; Laura Marandino; Hui-Ming Lin; Luigi Tortola; Ricardo Pereira Mestre; Martino Pedrani
Cytoplasmic versus nuclear localization of androgen receptor splice variant 7 as a predictor of benefit from androgen receptor pathway inhibitors in metastatic castration-resistant prostate cancer (PROPHECY trial)

雄激素受体剪接变体7的细胞质与核定位作为预测转移性去势抵抗性前列腺癌中雄激素受体通路抑制剂获益的指标（PROPHECY试验）

Prostate Cancer and Prostatic Diseases
IF5.8
2026-04-020
PRE
Santosh Gupta; Siyuan Guo; Susan Halabi; Chenxi Yu; Hyotae Kim; Jane McKenzie; Daniel J. George; David M. Nanus; Russell Z. Szmulewicz; Daniel C. Danila; Jun Luo; Emmanuel S. Antonarakis; Andrew J. Armstrong
Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: CAPItello-281 Phase III study

Capivasertib 联合 Abiraterone 治疗 PTEN 缺失的转移性激素敏感性前列腺癌：CAPItello-281 III 期研究

Annals of Oncology
IF65.4
2025-10-190
OAAI
Karim Fizazi; Noel W. Clarke; Maria De Santis; Hirotsugu Uemura; Andre P. Fay; Nuri Karadurmus; Mariusz Kwiatkowski; Carlos Alvarez-Fernandez; Shusuan Jiang; Miguel Sotelo; Dominique Parslow; Niara Oliveira; Tae Gyun Kwon; Dingwei Ye; Steve Boudewijns; Pongwut Danchaivijitr; Claire Rooney; Christopher Gresty; Marc Yeste-Velasco; Jill Logan; Daniel J. George
Plain language summary: does race or income status affect the cancer treatments that patients with metastatic castration-sensitive prostate cancer (mCSPC) receive in the United States?

通俗易懂的总结：种族或收入状况是否会影响美国患有转移性去势敏感前列腺癌（mCSPC）的患者的癌症治疗方案？

FUTURE ONCOLOGY
IF2.6
2025-04-250
OA
George, Daniel J.; Agarwal, Neeraj; Ramaswamy, Krishnan; Klaassen, Zachary; Bitting, Rhonda L.; Russell, David; Sandin, Rickard; Emir, Birol; Yang, Hongbo; Song, Wei; Lin, Yilu; Hong, Agnes; Gao, Wei; Freedland, Stephen J.
Plain language summary: how long do patients with metastatic castration-resistant prostate cancer (mCRPC) live when taking abiraterone or enzalutamide in the real world?

非专业语言摘要：在接受阿比特龙或恩扎卢特胺治疗时，转移性去势抵抗性前列腺癌（mCRPC）患者的真实世界生存期是多久？

FUTURE ONCOLOGY
IF2.6
2025-04-250
OA
George, Daniel J.; Ramaswamy, Krishnan; Yang, Hongbo; Liu, Qing; Zhang, Adina; Greatsinger, Alexandra; Ivanova, Jasmina; Thompson, Betty; Emir, Birol; Hong, Agnes; Freedland, Stephen J.
Intensifying Salvage Therapy in Prostate-specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy with Apalutamide, Salvage Radiation, and Docetaxel: The Phase 2 STARTAR Trial

在根治性前列腺切除术后前列腺特异性抗原复发性前列腺癌中应用阿帕卢他胺、挽救性放疗和多西他赛强化挽救治疗：STARTAR II期临床试验

European Urology Oncology
IF9.3
2024-07-010
PRE
Tian Zhang; Lauren Howard; Bridget F. Koontz; Scott T. Tagawa; Himanshu Nagar; Rhonda L. Bitting; Bart A. Frizzell; Luke Nordquist; Julia Rasmussen; Colleen Riggan; Marco Reyes; Catrin Davies; Steven R. Gray; Carly R. Newman; Escarleth Fernandez; Sundhar Ramalingam; Michael R. Harrison; Daniel J. George; Yuan Wu; Andrew J. Armstrong
Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer

短期醋酸阿比曲酮和LHRH激动剂治疗不良中危和高危前列腺癌的5年更新结果

PROSTATE CANCER AND PROSTATIC DISEASES
IF5.8
2024-02-220
PRE
Fecteau, Ryan E.; Koontz, Bridget F.; Hoffman, Karen E.; Halabi, Susan; Howard, Lauren E.; Anand, Monika; George, Daniel J.; Zhang, Tian; Berry, William R.; Lee, W. Robert; Harrison, Michael R.; Corn, Paul G.; Armstrong, Andrew J.
Prognostic and predictive analyses of circulating plasma biomarkers in men with metastatic castration resistant prostate cancer treated with docetaxel/prednisone with or without bevacizumab

多西他赛/泼尼松联合或不联合贝伐单抗治疗的转移性去势抵抗性前列腺癌患者循环血浆生物标志物的预后和预测分析

PROSTATE CANCER AND PROSTATIC DISEASES
IF5.8
2024-02-121
PRE
Nixon, Andrew B.; Liu, Yingmiao; Yang, Qian; Luo, Bin; Starr, Mark D.; Brady, John C.; Kelly, Wm Kevin; Beltran, Himisha; Morris, Michael J.; George, Daniel J.; Armstrong, Andrew J.; Halabi, Susan
Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC)
BRITISH JOURNAL OF CANCER
IF6.8
2023-11-187
OA
Zhao, Jimmy L.; Antonarakis, Emmanuel S.; Cheng, Heather H.; George, Daniel J.; Aggarwal, Rahul; Riedel, Elyn; Sumiyoshi, Takayuki; Schonhoft, Joseph D.; Anderson, Amanda; Mao, Ninghui; Haywood, Samuel; Decker, Brooke; Curley, Tracy; Abida, Wassim; Feng, Felix Y.; Knudsen, Karen; Carver, Brett; Lacouture, Mario E.; Wyatt, Alexander W.; Rathkopf, Dana

研究方向

暂未获取到该数据
A
Andrew J. Armstrong
H 指数:72论文数:1,022被引数:3.2万
S
Susan Halabi
H 指数:81论文数:782被引数:3.2万
M
Michael R. Harrison
H 指数:47论文数:302被引数:1.1万
S
Steven R. Patierno
H 指数:51论文数:320被引数:7,689
J
Jennifer A. Freedman
H 指数:19论文数:161被引数:857
K
Krishnan Ramaswamy
H 指数:18论文数:100被引数:1,787
N
Neal D. Shore
H 指数:84论文数:1,298被引数:4.5万
T
Tian Zhang
H 指数:47论文数:602被引数:1.3万
F
Fred Saad
H 指数:127论文数:1,909被引数:10.7万
M
Monika Anand
H 指数:17论文数:112被引数:1,295